ADA and systemic lupus erythematosus: Similarly, ADA levels are associated with disease activation in patients with other autoimmune diseases, such as systemic lupus erythematosus, juvenile idiopathic arthritis, rheumatoid arthritis, and Still’s disease (Torgutalp et al., 2017).